RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GALT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Galectin Therapeutics Inc. stock price ended at $2.41 on Wednesday, after gaining 1.69%.
(Updated on Mar 27, 2024)

Buy or Hold candidate since Feb 27, 2024 Gain 29.57% PDF

The Galectin Therapeutics Inc. stock price gained 1.69% on the last trading day (Wednesday, 27th Mar 2024), rising from $2.37 to $2.41. During the last trading day the stock fluctuated 3.20% from a day low at $2.35 to a day high of $2.42. The price has risen in 6 of the last 10 days and is up by 21.72% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 82 thousand shares were bought and sold for approximately $198.23 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $2.47 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 29.56% during the next 3 months and, with a 90% probability hold a price between $2.48 and $3.20 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GALT Signals & Forecast

The Galectin Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.33 and $1.97. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Galectin Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 22, 2024, and so far it has fallen -1.23%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Galectin Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.06 and $1.89. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galectin Therapeutics Inc. finds support just below today's level at $2.06. If this is broken, then the next support from accumulated volume will be at $1.89 and $1.86.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0750 between high and low, or 3.20%. For the last week, the stock has had daily average volatility of 7.03%.

Our recommended stop-loss: $2.31 (-4.04%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (GALT) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Galectin Therapeutics Inc. to open at $2.39, and during the day (based on 14 day Average True Range), to move between $2.29 and $2.53, which gives a possible trading interval of +/-$0.122 (+/-5.04%) up or down from last closing price. If Galectin Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.09% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.44 (1.24%) than the support at $2.06 (14.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Galectin Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Galectin Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.785 Buy Candidate Unchanged

Predicted Opening Price for Galectin Therapeutics Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.39 ( 0.761%) $2.41

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GALT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.47 2.35 %
R2 2.44 1.16 %
R1 2.42 0.428 %
Current price: 2.41
Support S1 2.36 -1.95 %
S2 2.35 -2.68 %
S3 2.32 -3.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 2.44 1.24 %
Current price 2.41
Support S1 2.06 -14.52%
S2 1.89 -21.58%
S3 1.86 -22.82%

FAQ

What is the symbol for Galectin Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Galectin Therapeutics Inc. is GALT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galectin Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Galectin Therapeutics Inc. stock to perform well in the short-term.

How to buy Galectin Therapeutics Inc. Stock?
Galectin Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galectin Therapeutics Inc. Stock.

What's the current price of Galectin Therapeutics Inc. Stock?
As of the end of day on the 2024-03-27, the price of an Galectin Therapeutics Inc. (GALT) share was $2.41.

What is the 52-week high and low for Galectin Therapeutics Inc. Stock?
The 52-week high for Galectin Therapeutics Inc. Stock is $2.48 and the 52-week low is $1.28.

What is the market capitalization of Galectin Therapeutics Inc. Stock?
As of the 2024-03-27, the market capitalization of Galectin Therapeutics Inc. is 146.581M.

When is the next earnings date for Galectin Therapeutics Inc.?
The upcoming earnings date for Galectin Therapeutics Inc. is Apr 04, 2024.
Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT